Credit rating agency CRISIL has reaffirmed ‘B+’ rating to Alchemist’s long term bank facilities. The rating agency has also reaffirmed ‘A4’ rating to the company’s short term bank facilities.
The ratings continue to reflect the continuous decline in the Alchemist group’s operating profitability, its large working capital requirements, and its high gearing. These rating weaknesses are partially offset by the group’s long track record in the food-processing and pharmaceutical industries with an established clientele, and its healthy debt protection metrics.
Alchemist has grown into a diversified corporation with operations in chemical trading, pharmaceuticals, food-processing, floriculture, and steel.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1787.10 |
| Dr. Reddys Lab | 1271.75 |
| Cipla | 1376.25 |
| Zydus Lifesciences | 1097.90 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: